Lina Daouk-Öyry, PhD Associate Professor in Organizational Behavior and HR Management Director of Evidence-based Healthcare Management Unit (EHMU)| AUB OSB Beirut, Lebanon
Lina Daouk-Öyry is an Assistant Professor of Organizational Behavior and Human Resource Management at the Olayan School of Business (OSB) at the American University of Beirut (AUB), specializing in employee assessment, development, and retention particularly in the healthcare sector. Lina is interested in exploring personality, competencies, and other individual differences among healthcare professionals (physicians, nurses, and hospital middle managers) and how they influence job related variables relevant to today's business context. Lina is also the Founding Director of the Evidence-based Healthcare Management Unit (EHMU), a cross-disciplinary unit based at AUBMC, which promotes the use of data and evidence for improving decision-making and consequently employee experience and service delivery in hospital settings.
Ghada El-Hajj Fuleihan, MD, MPH, FRCP
Professor of Medicine, Founding Director of Calcium Metabolism and Osteoporosis Program, and WHO Collaborating Center for Metabolic Bone Disorders Scholars in Health Research Program at American University of Beirut, Lebanon
Dr. Ghada El-Hajj Fuleihan is Professor of Medicine, Physician-Scientist, at the American University of Beirut (AUB), Beirut, Lebanon. She is founding Director of the Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, and of the Scholars in HeAlth Research Program at AUB. Dr. El-Hajj Fuleihan obtained her MD degree from the American University of Beirut (AUB), completed residency and fellowship training at the New England Deaconess and Brigham and Women’s Hospital, Harvard Medical School, Boston. She holds a master in Public Health from the Harvard School of Public Health, Clinical Effectiveness concentration. She is the PI/PD on multiple investigator initiated grants, including the NIH D43 capacity-building grant, awarded a 5-year competitive renewal (2020-2025). Dr. El-Hajj Fuleihan’s laboratory focuses on generating evidence on the pathophysiology, prevention, and treatment of hypovitaminosis D, osteoporosis, and other metabolic bone disorders. She leads a team that conducts clinical trials, systematic reviews, and meta-analyses, and translates findings into prevention and treatment strategies. She closely collaborates with the Ministry of Health officials and international experts to generate evidence-based national and international care pathways. These include guidance and guidelines on metabolic bone diseases, by OSTEOS, ISCD, IOF, ASBMR and the Endocrine Society. She led the IOF Middle East Africa audit, launched FRAX Lebanon, the first fracture risk calculator in the Middle East. She has mentored over 64 postgraduate trainees and junior faculty; several are pursuing careers in clinical translational research, at AUB, or in the US.
Dr. El-Hajj Fuleihan has published on her topics of interest in over 190 publications, mostly peer reviewed original investigations, chapters, invited reviews, and penned invited several Editorials, Scientific Position Statements, and commentaries in the New England of Medicine, and Journal of Clinical Endocrinology and Metabolism, and Nature Reviews Endocrinology. Dr. El-Hajj Fuleihan is a member of the Alpha Omega Alpha Medical Honor Society, and recipient of several awards including the 2013 International Society of Clinical Densitometry John P. Bilezikian Global Leadership Award, the 2016 Endocrine Society International Excellence in Endocrinology Laureate Award, and the 2017 Harvard T. Chan School of Public Health Award of Merit. She served as Clinical Science Chair, Endocrine Society’s Annual Meeting 2019; and serves a three year term on its board of directors. She also holds a lifelong appointment as the Bernard Lown Scholar in the Department of Global Health and Population, at the Harvard T.H.Chan School of Public Health.